The Board Meeting to be held on 18/05/2026 has been revised to 25/05/2026 The meeting of the Board of Directors of the Company has been rescheduled to May 25, 2026
AARTIPHARM · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Aarti Pharmalabs has informed exchanges that its Board Meeting scheduled for May 18, 2026 has been postponed to May 25, 2026. The meeting was originally called to consider matters that were outlined in an earlier intimation dated May 11, 2026. The company has also confirmed that the Trading Window will remain closed until 48 hours after the declaration of Financial Results for Q4 and FY ended March 31, 2026, which means trading restrictions will extend until May 27, 2026. This is a routine regulatory intimation under SEBI Listing Regulations and Insider Trading Regulations.
This is a routine administrative update with no material impact on shareholders. The postponement by one week does not indicate any adverse development and the financial results are still expected to be declared around the same timeframe.